Why Purity Matters in Research
Peptide-related impurities, such as deletion sequences or oxidized variants, can affect experimental results. However, a reported HPLC-UV purity of 95% by area means that the peak assigned to the intended peptide represents 95% of the integrated chromatographic peak area used in that calculation. It does not establish that the vial contains 5% impurities by mass. The remaining integrated peak area is not a complete inventory of contaminants, and the percentage does not identify each other component. Detector response, separation and integration affect the result; some compounds may co-elute or may not be detected under that method. Define the required specification for the research application rather than treating one purity threshold as sufficient for every project.
What an HPLC Purity Result Actually Measures
High-performance liquid chromatography separates components under specified analytical conditions. For peptide analysis with UV detection, purity is commonly reported as the area of the peak assigned to the target peptide relative to the total integrated peak area included in the analysis. Read the reporting basis, method, chromatogram and integration information together. Area percentage is not automatically a mass fraction or an absolute quantity assay. Identity is a separate question: mass spectrometry can provide molecular-mass evidence consistent with an expected peptide, but a mass match alone does not establish every structural feature. Acceptable mass accuracy depends on the instrument, method and compound; there is no single tolerance that applies to every peptide report.
Purity, Peptide Content and the Vial Label Are Different
Distinguish the nominal quantity on a vial label from an analytical purity result and a measured content result. Lyophilized material can contain water and counterions; those contributions are not established by the same HPLC-UV area measurement. Net peptide content describes peptide material relative to non-peptidic material and can include peptide-related impurities, so it is not automatically the measured amount of only the intended peptide. If a report includes a content assay, check what was quantified, the method, units and reporting basis. Do not infer a target-peptide quantity by multiplying the vial's label quantity by an HPLC area percentage. Match the compound and lot, preserve the original report, and record identity evidence, purity, any content result, the laboratory, report reference and test date separately.
Evaluating Suppliers
Apply the same documentation checks to every supplier: request the report for the relevant lot, identify the analytical methods and results, and seek clarification about missing evidence. Price, packaging, domestic location or a laboratory logo does not independently verify the material. Use the laboratory's official route to confirm a report where possible, while recognizing that report issuance does not prove sample custody for the vial in hand. A purity percentage does not establish unreported endotoxin, microbial, heavy-metal or residual-solvent results. Review only the tests actually listed and determine which additional evidence the research application requires. When considering Peptriva, compare its current lot documentation and specifications against this same framework; this guide does not independently certify a supplier or authenticate a batch.
Technical references
These sources explain the analytical methods and peptide-content distinction; they do not authenticate a particular report or endorse a supplier.
Quality documentation toolkit
Continue your COA review
Use the same repeatable documentation checks across every research peptide review. COA Check organizes visible document fields; laboratory verification remains the route for authenticity confirmation.